Although bone-marrow chimeras with an IL-10-deficient peripheral immune compartment displayed significantly larger infarcts at 3 days following tMCAO, when compared to bone-marrow chimeras with an IL-10-deficiency in brain resident cells, brain atrophy was not significantly altered at 14 days between both groups. Here, IL10 is linked to Brain atrophy.